166 related articles for article (PubMed ID: 37746061)
1. Impaired RNA Binding Does Not Prevent Histone Modification Changes in a FUS ALS/FTD Yeast Model.
Bennett SA; Cobos SN; Son E; Segal R; Mathew S; Yousuf H; Torrente MP
MicroPubl Biol; 2023; 2023():. PubMed ID: 37746061
[TBL] [Abstract][Full Text] [Related]
2. Trichostatin A Relieves Growth Suppression and Restores Histone Acetylation at Specific Sites in a FUS ALS/FTD Yeast Model.
Bennett SA; Cobos SN; Mirzakandova M; Fallah M; Son E; Angelakakis G; Rana N; Hugais M; Torrente MP
Biochemistry; 2021 Dec; 60(48):3671-3675. PubMed ID: 34788013
[TBL] [Abstract][Full Text] [Related]
3. Neuronal dysfunction caused by FUSR521G promotes ALS-associated phenotypes that are attenuated by NF-κB inhibition.
Pelaez MC; Desmeules A; Gelon PA; Glasson B; Marcadet L; Rodgers A; Phaneuf D; Pozzi S; Dutchak PA; Julien JP; Sephton CF
Acta Neuropathol Commun; 2023 Nov; 11(1):182. PubMed ID: 37974279
[TBL] [Abstract][Full Text] [Related]
4. FUS mutations dominate TBK1 mutations in FUS/TBK1 double-mutant ALS/FTD pedigrees.
Brenner D; Müller K; Lattante S; Yilmaz R; Knehr A; Freischmidt A; Ludolph AC; Andersen PM; Weishaupt JH
Neurogenetics; 2022 Jan; 23(1):59-65. PubMed ID: 34518945
[TBL] [Abstract][Full Text] [Related]
5. FUS-regulated RNA metabolism and DNA damage repair: Implications for amyotrophic lateral sclerosis and frontotemporal dementia pathogenesis.
Zhou Y; Liu S; Oztürk A; Hicks GG
Rare Dis; 2014; 2():e29515. PubMed ID: 25083344
[TBL] [Abstract][Full Text] [Related]
6. Pathogenesis of FUS-associated ALS and FTD: insights from rodent models.
Nolan M; Talbot K; Ansorge O
Acta Neuropathol Commun; 2016 Sep; 4(1):99. PubMed ID: 27600654
[TBL] [Abstract][Full Text] [Related]
7. Conformational change of RNA-helicase DHX30 by ALS/FTD-linked FUS induces mitochondrial dysfunction and cytosolic aggregates.
Hikiami R; Morimura T; Ayaki T; Tsukiyama T; Morimura N; Kusui M; Wada H; Minamiyama S; Shodai A; Asada-Utsugi M; Muramatsu SI; Ueki T; Takahashi R; Urushitani M
Sci Rep; 2022 Sep; 12(1):16030. PubMed ID: 36163369
[TBL] [Abstract][Full Text] [Related]
8. Lysine acetylation regulates the RNA binding, subcellular localization and inclusion formation of FUS.
Arenas A; Chen J; Kuang L; Barnett KR; Kasarskis EJ; Gal J; Zhu H
Hum Mol Genet; 2020 Sep; 29(16):2684-2697. PubMed ID: 32691043
[TBL] [Abstract][Full Text] [Related]
9. Mutation of the ALS/FTD-associated RNA-binding protein FUS affects axonal development.
Tartwijk FWV; Wunderlich LCS; Mela I; Makarchuk S; Jakobs MAH; Qamar S; Franze K; Schierle GSK; George-Hyslop PHS; Lin JQ; Holt CE; Kaminski CF
J Neurosci; 2024 May; ():. PubMed ID: 38692734
[TBL] [Abstract][Full Text] [Related]
10. Rapid in vitro quantification of TDP-43 and FUS mislocalisation for screening of gene variants implicated in frontotemporal dementia and amyotrophic lateral sclerosis.
Oyston LJ; Ubiparipovic S; Fitzpatrick L; Hallupp M; Boccanfuso LM; Kwok JB; Dobson-Stone C
Sci Rep; 2021 Jul; 11(1):14881. PubMed ID: 34290285
[TBL] [Abstract][Full Text] [Related]
11. Expression of Fused in sarcoma mutations in mice recapitulates the neuropathology of FUS proteinopathies and provides insight into disease pathogenesis.
Verbeeck C; Deng Q; Dejesus-Hernandez M; Taylor G; Ceballos-Diaz C; Kocerha J; Golde T; Das P; Rademakers R; Dickson DW; Kukar T
Mol Neurodegener; 2012 Oct; 7():53. PubMed ID: 23046583
[TBL] [Abstract][Full Text] [Related]
12. Loss of Dynamic RNA Interaction and Aberrant Phase Separation Induced by Two Distinct Types of ALS/FTD-Linked FUS Mutations.
Niaki AG; Sarkar J; Cai X; Rhine K; Vidaurre V; Guy B; Hurst M; Lee JC; Koh HR; Guo L; Fare CM; Shorter J; Myong S
Mol Cell; 2020 Jan; 77(1):82-94.e4. PubMed ID: 31630970
[TBL] [Abstract][Full Text] [Related]
13. Multi-omics profiling identifies a deregulated FUS-MAP1B axis in ALS/FTD-associated UBQLN2 mutants.
Strohm L; Hu Z; Suk Y; Rühmkorf A; Sternburg E; Gattringer V; Riemenschneider H; Berutti R; Graf E; Weishaupt JH; Brill MS; Harbauer AB; Dormann D; Dengjel J; Edbauer D; Behrends C
Life Sci Alliance; 2022 Nov; 5(11):. PubMed ID: 35777956
[TBL] [Abstract][Full Text] [Related]
14. Ubiquilin 2 modulates ALS/FTD-linked FUS-RNA complex dynamics and stress granule formation.
Alexander EJ; Ghanbari Niaki A; Zhang T; Sarkar J; Liu Y; Nirujogi RS; Pandey A; Myong S; Wang J
Proc Natl Acad Sci U S A; 2018 Dec; 115(49):E11485-E11494. PubMed ID: 30442662
[TBL] [Abstract][Full Text] [Related]
15. ALS/FTD-Linked Mutation in FUS Suppresses Intra-axonal Protein Synthesis and Drives Disease Without Nuclear Loss-of-Function of FUS.
López-Erauskin J; Tadokoro T; Baughn MW; Myers B; McAlonis-Downes M; Chillon-Marinas C; Asiaban JN; Artates J; Bui AT; Vetto AP; Lee SK; Le AV; Sun Y; Jambeau M; Boubaker J; Swing D; Qiu J; Hicks GG; Ouyang Z; Fu XD; Tessarollo L; Ling SC; Parone PA; Shaw CE; Marsala M; Lagier-Tourenne C; Cleveland DW; Da Cruz S
Neuron; 2018 Nov; 100(4):816-830.e7. PubMed ID: 30344044
[TBL] [Abstract][Full Text] [Related]
16. FUS contributes to mTOR-dependent inhibition of translation.
Sévigny M; Bourdeau Julien I; Venkatasubramani JP; Hui JB; Dutchak PA; Sephton CF
J Biol Chem; 2020 Dec; 295(52):18459-18473. PubMed ID: 33082139
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of FUS mutations in familial amyotrophic lateral sclerosis.
Shang Y; Huang EJ
Brain Res; 2016 Sep; 1647():65-78. PubMed ID: 27033831
[TBL] [Abstract][Full Text] [Related]
18. FUS regulates RAN translation through modulating the G-quadruplex structure of GGGGCC repeat RNA in
Fujino Y; Ueyama M; Ishiguro T; Ozawa D; Ito H; Sugiki T; Murata A; Ishiguro A; Gendron T; Mori K; Tokuda E; Taminato T; Konno T; Koyama A; Kawabe Y; Takeuchi T; Furukawa Y; Fujiwara T; Ikeda M; Mizuno T; Mochizuki H; Mizusawa H; Wada K; Ishikawa K; Onodera O; Nakatani K; Petrucelli L; Taguchi H; Nagai Y
Elife; 2023 Jul; 12():. PubMed ID: 37461319
[TBL] [Abstract][Full Text] [Related]
19. Dendritic Homeostasis Disruption in a Novel Frontotemporal Dementia Mouse Model Expressing Cytoplasmic Fused in Sarcoma.
Shiihashi G; Ito D; Arai I; Kobayashi Y; Hayashi K; Otsuka S; Nakajima K; Yuzaki M; Itohara S; Suzuki N
EBioMedicine; 2017 Oct; 24():102-115. PubMed ID: 28928015
[TBL] [Abstract][Full Text] [Related]
20. Elevated FUS levels by overriding its autoregulation produce gain-of-toxicity properties that disrupt protein and RNA homeostasis.
Ho WY; Ling SC
Autophagy; 2019 Sep; 15(9):1665-1667. PubMed ID: 31230528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
